Covering the entire scope of the healthcare and life sciences sector, Taylor Wessing has strengths in long-term healthcare transactional advice; ongoing patent, licensing and employment law counselling; and contentious drug advertising and competition law cases. With particular strength in disputes, the practice has led in some of the most prominent cases of patent infringement and product liability litigation in the pharmaceutical and medical device industry, where Henning Moelle is a leading name; a recent work highlight is representing major global pharmaceutical firms on Covid-19 vaccine liability proceedings. On the transactional side of the team, Oliver Kirschner and Oliver Klöck have experience in healthcare company and facility M&A on the buy and sell-sides, and Daniel Tietjen leads in matters concerning drug advertising law.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Experts in life sciences advertising law and good litigators. They are responsive and easy to work with, and patient in explaining legal concepts to a foreign audience.’
- 'Taylor Wessing’s healthcare and life sciences practice is unique in combining deep regulatory expertise with strong transactional capabilities and true industry insight. Taylor Wessing advises us not only from a legal perspective but also with a genuine understanding of our business models and challenges. We particularly value the team’s responsiveness, pragmatic approach, and ability to deliver comprehensive solutions across all fields of our activities in the market - all within one coordinated structure.'
- 'The experts we work with at Taylor Wessing stand out through a combination of deep technical expertise, industry knowledge, and personal commitment. They combine first-class legal advice with a pragmatic, solution-oriented mindset that consistently addresses the commercial realities of our business. Our standout partner is Vanessa Vollmar: her in-depth expertise in healthcare and life sciences is exceptional, particularly in advising on complex contractual, commercial, and regulatory structures.'
- 'Deep expertise in healthcare and life sciences, with a strong regulatory and commercial perspective. Compared to other firms they are pragmatic, solutions-oriented and highly efficient. Strong collaboration across partners and associates, seamless integration. Professional yet approachable style of working, making complex matters manageable.'
- 'The team is extremely responsive and has a very pragmatic, solution-focused approach. The team has a specialist approach, where certain matters are handled by certain members with greater expertise in the specific matter.'
- 'Daniel Tietjen is a very experienced lawyer with profound knowledge in life sciences matters. He is very approachable and open to informal sparring, which I find very helpful in my practice.'
Key clients
- Abbott Laboratories
- AstraZeneca
- Bayer
- Pfizer
- Grünenthal
- STADA
- Zentiva
- Asklepios Kliniken
- Fresenius Kabi SwissBioSim
- Angelini Pharma
- Cochlear
- Daiichi Sankyo
Work highlights
Represented AstraZeneca in all product liability proceedings relating to its COVID-19 vaccine.
Advised Biospring on master service agreements for the manufacture of oligonucleotide molecules for numerous domestic and foreign pharmaceutical and biotechnology companies.
Coordinated the international court defence for Abbott against infringement actions concerning continuous glucose monitoring products.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Oliver Kirschner
Other key lawyers
Henning Moelle; Oliver Klöck; Daniel Tietjen; Vanessa Vollmar